Evidence map›Paper›PMID 41732916›Full record

ArticleNucleic acids research2026

Dynamic landscape of transcription initiation by yeast RNA polymerase I.

Olena Parilova, Piia Bartos, Anssi M Malinen

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olena ParilovaDepartment of Life Technologies, University of Turku, Turku 20014, Finland.ORCID 0000-0003-2282-4425
Piia BartosSchool of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland.ORCID 0000-0001-6002-1856
Anssi M MalinenDepartment of Life Technologies, University of Turku, Turku 20014, Finland.ORCID 0000-0003-2987-2649

Funding

Emil Aaltosen SäätiöResearch Council of Finland 307775Research Council of Finland 314100Research Council of Finland 335377Sigrid Juseliuksen säätiöSigrid Juséliuksen säätiöSuomen KulttuurirahastoTurun YliopistosäätiöUniversity of Turku Graduate School
6 · The paper itself

Abstract

RNA polymerase I (Pol I) synthesizes precursor ribosomal RNA, a key step in ribosome biogenesis. Elevated Pol I activity supports rapid cell growth-a hallmark of cancer-making Pol I a therapeutic target. The initial step in synthesis involves assembly of the Pol I transcription initiation complex on the gene promoter; however, its quantitative and dynamic parameters remain poorly defined. Here, we integrate biochemical, biophysical, and molecular dynamics approaches to dissect promoter and transcription start site (TSS) recognition by the Saccharomyces cerevisiae Pol I machinery. We show that core factor (CF) identifies the promoter through a two-step mechanism: a rapid encounter is followed by a slower conformational transition that establishes stabilizing interactions. In contrast, CF binds nonpromoter DNA in a single step without such transitions, forming nonspecific complexes that dissociate quickly. Correct promoter binding allows CF to recruit and position Pol I near the TSS, inducing DNA bending, helix distortion, and melting as the preinitiation complex converts into an active state. These functional and dynamic parameters contribute to a quantitative framework for elucidating the molecular mechanisms of Pol I regulation and inhibition.

Indexed as

RNA Polymerase ISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription Initiation, GeneticTranscription Initiation SiteDNAMolecular Dynamics SimulationPromoter Regions, GeneticDNARNA Polymerase ISaccharomyces cerevisiae Proteins

Identifiers

PMID41732916
PMCPMC12956329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.